| Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout | Alex Lash | 05/18/18 | National |
| “Wrong to Toast”: Broad’s Lander Sorry for Tribute to DNA Pioneer Watson | Alex Lash | 05/14/18 | Boston |
| Save $100 Today on “What’s Hot in Boston Biotech” on May 16 | Ashley Gentile | 05/02/18 | Boston |
| Join Feng Zhang, Eric Lander, Craig Mello & More at What’s Hot in Boston Biotech | Ashley Gentile | 03/19/18 | Boston |
| Bio Roundup: Trump Health, Cholesterol Wars, 23andMe OK & More | Alex Lash | 03/09/18 | National |
| Paying for Gene Therapy, CRISPR in People, RNAi at “What’s Hot” on May 16 | Ben Fidler | 03/05/18 | Boston |
| Watson Health and Broad Institute Team Up for $50M Cancer Collaboration | Gregory T. Huang | 11/10/16 | Boston |
| Biotech’s Recent Headlines, Reimagined In Verse and On Stage | Alex Lash | 02/16/16 | National |
| As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO | Alex Lash | 01/25/16 | Boston |
| Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M | Ben Fidler | 11/17/15 | Boston |
| From Dance Clubs to Syn Bio: MIT’s Collins on Startups, Second Chances | Ben Fidler | 10/05/15 | Boston |
| East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More | Ben Fidler | 10/02/15 | Boston |
| Famed Geneticist Altshuler Bolts Broad Institute for Vertex | Ben Fidler | 12/15/14 | Boston |
| David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech | Ben Fidler | 10/16/13 | Boston |
| Broad Institute Joins up with Bayer to Find Targeted Cancer Drugs | Ben Fidler | 09/10/13 | Boston |
| Zuckerberg Takes a Small Step in Right Direction, Backing Biotech | Luke Timmerman | 02/25/13 | National |
| East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More | Bernadette Tansey | 02/22/13 | New York |
| Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars | Luke Timmerman | 02/20/13 | National |
| Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 | Luke Timmerman | 11/07/11 | National |
| Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News | Erin Kutz | 11/04/11 | Boston |
| Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO | Luke Timmerman | 11/03/11 | Boston |
| BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News | Erin Kutz | 07/20/11 | Boston |
| Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News | Erin Kutz | 07/15/11 | Boston |
| Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors | Arlene Weintraub | 07/14/11 | Boston |
| Termeer Joins Verastem Board | Luke Timmerman | 06/13/11 | Boston |
| An Innovation Walk in the Snow: Can You Guess My Route? | Robert Buderi | 01/19/11 | Boston |
| Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News | Erin Kutz | 11/19/10 | Boston |
| Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells | Luke Timmerman | 11/16/10 | Boston |
| Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes | Ryan McBride | 04/14/10 | Boston |
| The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News | Luke Timmerman | 11/19/09 | Seattle |
